NKE vs UNH: Which Is the Better Buy?

Side-by-side comparison of NIKE, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
NIKE, Inc. · Consumer Cyclical
$42.62
+45.5% upside to fair value
Med Conviction Grade B+
VS
UnitedHealth Group Incorporated · Healthcare
$304.33
+41.3% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NKE has more upside to fair value (+45.5%). UNH trades at a lower forward P/E (15.1x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric NKE UNH
Current Price $42.62 $304.33
Fair Value Estimate $62.00 $430.00
Upside to Fair Value +45.5% +41.3%
Market Cap $63.0B $276.2B
Forward P/E 27.9x 15.1x
EV / EBITDA 20.7x 14.3x
Price / Sales 1.4x 0.6x
Price / FCF 19.4x 17.2x
Revenue Growth YoY -9.8% +11.8%
Gross Margin 42.7% 18.5%
Operating Margin 8.0% 4.2%
Return on Equity 24.4% 12.7%
Dividend Yield 3.8% 2.9%
FCF Yield 5.2% 5.82%
Analyst Consensus Buy Buy
Investment Thesis
NKE — NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
UNH — UnitedHealth Group Incorporated
UnitedHealth Group is the world's largest diversified healthcare company, combining the dominant US health insurer UnitedHealthcare with the high-margin Optum services platform spanning care delivery, pharmacy benefits, and data analytics. The stock has fallen roughly 49% from its 2024 peak of $596, driven by elevated medical costs, DOJ antitrust scrutiny, CEO transitions (Brian Thompson's murder…
Accumulation Zones
Metric NKE UNH
Zone Low $44.00 $280.00
Zone High $50.00 $340.00
In Buy Zone? Yes Yes
← NKE Research    UNH Research →    All Research